Atlas Trials

A Study in Recurrent or Metastatic Cervical Cancer Patients With PD-L1 Positive

Clinical trial NCT03808857 · UNKNOWN

Trial details

NCT number
NCT03808857
Sponsor
Genor Biopharma Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Cervical Cancer
Start date
2019-05-23
Primary completion
2021-12-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.